Advertisement
Screener

Indivior Pharmaceuticals, Inc. (SUPN) Other

Indivior Pharmaceuticals, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-08-03: Form 10-Q; Item Shares outstanding as of 2026-07-28; As filed 58,127,013.
  • 2026-05-05: Form 10-Q; Item Shares outstanding as of 2026-04-28; As filed 58,039,721.
  • 2026-03-02: Form 10-K; Item Shares outstanding as of 2026-02-24; As filed 57,581,712.
  • 2026-03-02: Form 10-K; Item Public float as of 2025-06-30; As filed $1.69B.
FiledFormItemAs filed
2026-08-0310-QShares outstanding as of 2026-07-2858,127,013
2026-05-0510-QShares outstanding as of 2026-04-2858,039,721
2026-03-0210-KShares outstanding as of 2026-02-2457,581,712
2026-03-0210-KPublic float as of 2025-06-30$1.69B
2026-03-0210-KStock registered under Section 12(b)Common Stock, $0.001 Par Value · SUPN · NASDAQ

Similar stocks

Stock NameCountryMarket CapPE Ratio
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38